Condition

Systemic Lupus

ClinicalTrials.gov condition label

Clinical trials5

Recruiting0

Common interventions5

Lead sponsors shown4

Clinical trials

5 shown

ASA Patterns for Prevention of Preeclampsia in SLE PregnanciesNCT03749044 · 2018-05-28

COMPLETED

Evaluation of Influenza A/H3N2 Vaccine in Patients With Rheumatologic DiseasesNCT03540823 · 2018-04-23

COMPLETED

Volatile Organic Compounds (VOCs) as a Biomarker in Immune-mediated Pulmonary Arterial Hypertension (PAH)NCT03819777 · 2018-03-01

UNKNOWN

Yellow Fever Vaccine in Patients With Rheumatic DiseasesNCT03430388 · 2018-01-31

COMPLETED

Combined Pneumococcal Conjugate and Polysaccharide Vaccination in Inflammatory Rheumatic DiseaseNCT03762824 · 2016-06-14

COMPLETED

Common interventions

13-valent pneumococcal conjugate vaccineBIOLOGICAL123-valent pneumococcal polysaccharide vaccineBIOLOGICAL1Inactivated and fragmented influenza vaccine (A / Michigan / 45/2015 (H1N1) pdm09-like virus, A / Singapore / INFIMH-16-0019 / 2016 (H3N2) -like virus; B / Phuket / 3073/2013-like virus)BIOLOGICAL1Patient Educational ToolOTHER1Yellow Fever vaccine (17D)BIOLOGICAL1

Leading sponsors

University of Sao Paulo General Hospital2Maastricht University Medical Center1McGill University Health Centre/Research Institute of the McGill University Health Centre1Region Skane1

Trial status mix

COMPLETED4

UNKNOWN1

Phase mix

NA2

PHASE42

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.